Austria recalls batch of AstraZeneca while death is investigated – Health and Healthy Living

Credit: CC0 Public Domain Austria will stop using doses from one batch of the AstraZeneca vaccine while the death of a nurse who received it is investigated, health officials said.

The decision was taken as a precaution, the National Office for Health System Security (BASG) said on Sunday night, adding that there was “no evidence of a causal link” between the puncture and the woman’s death.

The 49-year-old nurse died two days after receiving the injection from “serious blood clotting problems” and another woman who received an injection from the same batch developed a pulmonary embolism but is now recovering.

Both women received the vaccine at a hospital in the town of Zwettl, west of the capital Vienna.

An autopsy is being carried out at Vienna’s AKH hospital on the woman who died, with results expected in the coming weeks.

“Based on known clinical data, a causal relationship cannot be established, as thrombotic events are not one of the typical side effects of vaccination,” the BASG statement. said.

“The necessary investigation is currently underway… to definitively rule out any possible link.”

Regional prosecutors confirmed to AFP that no legal action would be taken against the hospital as no anomalies had been reported in the delivery, storage or administration of the vaccine.

Since inoculation campaigns began in earnest, isolated cases have been reported in some countries of people dying shortly after receiving a vaccine.

None have been linked to the vaccine.

explore more

Follow the latest news about the coronavirus outbreak (COVID-19)

2021 AFP

Date: Austria recalls AstraZeneca batch when death probed (2021, March 8) Retrieved August 30, 2022 from https://medicalxpress.com/news/2021-03-austria-astrazeneca-batch-death-probed .html This document is subject to copyright. Other than any fair dealing for private study or research purposes, no part may be reproduced without written permission. The content is provided for informational purposes only.

Leave a Reply

Your email address will not be published.